NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma
View abstract on PubMed
Summary
This summary is machine-generated.Head and neck squamous cell carcinoma (HNSCC) involves the NSD1 gene, which drives tumor growth by activating Akt/mTORC1 signaling and autophagy. Targeting NSD1 may offer new therapeutic strategies for HPV-negative HNSCC.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Head and neck squamous cell carcinoma (HNSCC) is a prevalent cancer with a persistent 5-year survival rate of approximately 66%.
- Identifying drivers of HPV-negative HNSCC is crucial for developing targeted therapies and improving patient outcomes.
- NSD1, a histone methyltransferase, is implicated in HNSCC, with inactivating mutations correlating with better prognoses.
Purpose Of The Study
- To investigate the role of NSD1 in regulating cell growth, signaling pathways, and autophagy in HNSCC.
- To determine if NSD1 functions as a potential therapeutic target in head and neck cancer.
Main Methods
- Depletion of NSD1 in HNSCC cell lines and in vivo models.
- Analysis of cell growth, Akt/mTORC1 signaling pathway activation, and autophagic gene expression.
- Assessment of protein levels for p62, LC3B-II, and ULK1, and evaluation of autophagic flux.
Main Results
- NSD1 depletion significantly reduced HNSCC cell growth both in vitro and in vivo.
- NSD1 was found to promote Akt/mTORC1 signaling pathway activation.
- NSD1 knockdown induced an autophagic gene program, altered protein levels (p62, LC3B-II, ULK1), and disrupted autophagic flux.
Conclusions
- NSD1 positively regulates Akt/mTORC1 signaling and autophagy in HNSCC.
- These findings highlight novel functions of NSD1 in head and neck cancer.
- NSD1 represents a potential therapeutic target for HNSCC treatment.

